I still think the fundamentals are so good that it warrents a $5 to $10 share price. Traders have been spooked by articles about vaccine and tamiflu issues, however biota is not in the vaccine business. This quarterly is important as it should help alleviate concerns about relenza royalties. Then we can look forward to lani and hrv, and a higher share price. Till then, why sell at $2? I'm not.
biota to resume bull run
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)